These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26497849)

  • 41. Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.
    Cole KE; Ly QP; Hollingsworth MA; Cox JL; Padussis JC; Foster JM; Vargas LM; Talmadge JE
    Cell Immunol; 2021 May; 363():104317. PubMed ID: 33714729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases.
    Janols H; Bergenfelz C; Allaoui R; Larsson AM; Rydén L; Björnsson S; Janciauskiene S; Wullt M; Bredberg A; Leandersson K
    J Leukoc Biol; 2014 Nov; 96(5):685-93. PubMed ID: 24929004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
    Sato Y; Shimizu K; Shinga J; Hidaka M; Kawano F; Kakimi K; Yamasaki S; Asakura M; Fujii SI
    Oncoimmunology; 2015 Mar; 4(3):e995541. PubMed ID: 25949922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients.
    Wang Y; Li P; Wang B; Wang S; Liu P
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):523-533. PubMed ID: 30603902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells.
    Lim HX; Hong HJ; Cho D; Kim TS
    J Immunol; 2014 Dec; 193(11):5453-60. PubMed ID: 25362180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
    Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification and significance of myeloid-derived suppressor cells in peripheral blood of breast cancer patients].
    Wang CQ; Wei G; Xu GY; Wang JM; Bian J; Ma MS; Wang W; Xu D; Zhou ZJ; Zhao DD; Li H
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):118-23. PubMed ID: 26899331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
    Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
    Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.
    Salem ML; Zidan AA; Attia M; El-Naggar RE; Nassef M; Abou El-Azm AR; El-Bate H; Yussif M; Galal S; Abo Senna M; El Demellawy M
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):188-198. PubMed ID: 28472907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
    Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
    Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
    du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
    Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
    Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
    J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
    Du J; Sun X; Song Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
    Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
    J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.